X-136147638-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001159702.3(FHL1):c.-101+10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00035 ( 0 hom., 7 hem., cov: 19)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
FHL1
NM_001159702.3 intron
NM_001159702.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.311
Publications
0 publications found
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
- X-linked myopathy with postural muscle atrophyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- myopathy, reducing body, X-linked, early-onset, severeInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- reducing body myopathyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Emery-Dreifuss muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked scapuloperoneal muscular dystrophyInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-136147638-C-G is Benign according to our data. Variant chrX-136147638-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 390490.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000354 (38/107260) while in subpopulation AMR AF = 0.00145 (15/10342). AF 95% confidence interval is 0.000894. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001159702.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FHL1 | TSL:5 MANE Plus Clinical | c.-101+10C>G | intron | N/A | ENSP00000377710.2 | Q13642-2 | |||
| FHL1 | TSL:2 | c.-101+626C>G | intron | N/A | ENSP00000486439.1 | Q13642-1 | |||
| FHL1 | c.-101+10C>G | intron | N/A | ENSP00000499016.1 | Q13642-1 |
Frequencies
GnomAD3 genomes AF: 0.000354 AC: 38AN: 107222Hom.: 0 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
38
AN:
107222
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 620Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 142
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
620
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
142
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AF:
AC:
0
AN:
1
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AF:
AC:
0
AN:
5
South Asian (SAS)
AF:
AC:
0
AN:
505
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
95
Other (OTH)
AF:
AC:
0
AN:
10
GnomAD4 genome AF: 0.000354 AC: 38AN: 107260Hom.: 0 Cov.: 19 AF XY: 0.000232 AC XY: 7AN XY: 30158 show subpopulations
GnomAD4 genome
AF:
AC:
38
AN:
107260
Hom.:
Cov.:
19
AF XY:
AC XY:
7
AN XY:
30158
show subpopulations
African (AFR)
AF:
AC:
2
AN:
29581
American (AMR)
AF:
AC:
15
AN:
10342
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2614
East Asian (EAS)
AF:
AC:
0
AN:
3274
South Asian (SAS)
AF:
AC:
0
AN:
2334
European-Finnish (FIN)
AF:
AC:
0
AN:
5353
Middle Eastern (MID)
AF:
AC:
0
AN:
200
European-Non Finnish (NFE)
AF:
AC:
21
AN:
51469
Other (OTH)
AF:
AC:
0
AN:
1463
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Likely benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.